abstract |
In the present invention there is disclosed a pharmaceutical preparation for treating androgenic alopecia and containing 5alpha-reductase inhibitor in individual dosage below 5 mg/day intended for treating alopecia of male type and support of hair growth as well as for treating diseases such as acne vulgaris, steatorrhea and female hirsutism. |